Retina Consultants of Minnesota

Minneapolis, Minnesota 55435

2 studies enrolling now · 7 studies all time

What they study most

Age Related Macular Degeneration (ARMD), Diabetic Macular Edema, Geographic Atrophy of the Macula, Macular Degeneration, Macular Telangiectasia Type 2 (MacTel), Neovascular Age-related Macular Degeneration, Stickler Syndrome Type 1, Stickler Syndrome Type 2

Studies at this site

• Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
• Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS) — Recruiting now
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling
• Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema — Completed